In English
NIDA

Mujeres embarazadas

Substance Use in Women

Sex and Gender Differences in Substance Use

Women may face unique issues when it comes to substance use, in part influenced by:

NIDA announces two online resources

The National Institute on Drug Abuse (NIDA) is pleased to announce two online resources - Substance Use in Women and Therapeutic Communities Research Report.


Substance Use in Women

Examines women and substance use, including sex and gender differences in use, how substance use affects a mother and her baby, and sex and gender differences in drug addiction treatment.
 

Impresa en: julio del 2015

Women and Drugs

Brief Description

Prenatal Methamphetamine Exposure Linked With Problems

Study findings indicate that children exposed to methamphetamine prenatally show more signs of increased emotionality, anxiety, and depression than nonexposed children at ages 3 and 5 years.

Buprenorphine During Pregnancy Reduces Neonate Distress

Sublingual buprenorphine is a safe and effective alternative to methadone for treating opioid dependence during pregnancy, finds the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a NIDA-supported clinical trial. Women who received either medication had similar pregnancy and birth outcomes, but infants born to women who received buprenorphine had milder symptoms of neonatal opioid withdrawal.

Home Visits by Nurses to Low-Income First-Time Mothers Yield Enduring Benefits

A program involving home visits by nurses to low-income first-time mothers, starting during pregnancy and extending into the second year of their children’s lives, has a positive and long-lasting impact on families. Children who participated in the program were less likely than others to report having used alcohol, cigarettes, or marijuana at age 12.

Women and Sex/Gender Differences Research Program

NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

Research Focuses on Groups With High Smoking Rates

NIDA Director Nora Volkow
Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

Páginas

Take the IQ Challenge en Español!